Skip to Content

View Additional Section Content

Clinical Protocol CV010031 – A Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of BMS-986177, an Oral Factor XIa Inhibitor, for the Prevention of New Ischemic Stroke or New Covert Brain Infarction in Patients Receiving Aspirin and Clopidogrel Following Acute Ischemic Stroke or Transient Ischemic Attack (TIA)

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT03766581?term=986177&draw=3&rank=13

Clinical Trial Categories

  • Stroke Research
Contact
Patricia Bussinger, CRNP at 215-481-5373

Location

  • Abington Hospital
    1200 Old York Rd
    Abington, PA 19001

Find a Physician
Search Our Directory

215-481-MEDI
215-481-6334

Schedule a
Test

215-481-EXAM
215-481-3926